Dr. Nabil Elia Choueiri, MD

Dr. Choueiri practices at Salem Endoscopy Center in Salem, Oregon.

Dr. Choueiri's NPI, 1124220660, was assigned on June 5, 2007. Dr. Choueiri graduated from American University of Beirut Faculty of Medicine in 2002. Dr. Choueiri's Texas license number on file is P0713.

Dr. Choueiri's primary practice is Salem Endoscopy Center, at 875 Oak Street SE, Suite C3095, Salem, OR 97301. The practice phone is (503) 561-8170.

Dr. Choueiri's primary practice is Salem Endoscopy Center in Salem, Oregon. Dr. Choueiri is also affiliated with Salem Hospital. The medical group on file is Salem Gastroenterology Consultants. Dmand AI also links Dr. Choueiri to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Choueiri practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Choueiri's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Choueiri is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Choueiri's licenses on file in 3 states: Texas, Oregon and Maryland.

Dmand AI lists acid reflux, colonoscopy, irritable bowel syndrome (IBS), pancreas or bile duct endoscopy (ERCP) and upper GI endoscopy among the conditions Dr. Choueiri treats.

CMS data shows 684 Medicare services from Dr. Choueiri across 14 procedure codes in 2024, for 289 Medicare patients. Medicare paid $56,978 for them.

CMS counts 289 Medicare patients who saw Dr. Choueiri in 2024. The largest group is 65 to 74, with 154 patients. 67% of them have high blood pressure, and 65% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Choueiri's median patient age at 67, with 50% women.

In 2024, Dr. Choueiri wrote 866 Medicare Part D claims for 518 patients. 78% of them were for generic drugs. CMS names the drug for 662 of them, across 12 drugs with 11 or more claims each, at $37,562 in total drug cost. In 2023, CMS named 548 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 43 out of 100 for Dr. Choueiri for performance year 2024, reported as part of a group. Dr. Choueiri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 152 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Choueiri, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Choueiri, published from 2004 to 2014. Dr. Choueiri's most frequent co-author is Mark Thomas Voellinger, MD.

CMS Open Payments shows 42 general payments to Dr. Choueiri from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Boston Scientific Corporation paid the most, $984.

Dmand AI lists 1 award for Dr. Choueiri, most recently CMS Stage 1 EHR in 2013.

Dr. Choueiri graduated from American University of Beirut Faculty of Medicine in 2002.

Dr. Choueiri is in network with 14 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.